Barclays’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$469M Sell
4,367,451
-1,168,302
-21% -$125M 0.11% 93
2025
Q1
$558M Buy
5,535,753
+1,121,449
+25% +$113M 0.16% 69
2024
Q4
$394M Buy
4,414,304
+339,068
+8% +$30.3M 0.11% 97
2024
Q3
$342M Buy
4,075,236
+83,063
+2% +$6.96M 0.09% 136
2024
Q2
$307M Sell
3,992,173
-54,345
-1% -$4.19M 0.09% 138
2024
Q1
$277M Buy
4,046,518
+671,795
+20% +$46M 0.1% 158
2023
Q4
$195M Sell
3,374,723
-798,464
-19% -$46.2M 0.07% 201
2023
Q3
$220M Buy
4,173,187
+413,994
+11% +$21.9M 0.14% 156
2023
Q2
$203M Buy
3,759,193
+2,461,951
+190% +$133M 0.13% 152
2023
Q1
$64.9M Sell
1,297,242
-901,779
-41% -$45.1M 0.03% 261
2022
Q4
$102M Buy
2,199,021
+573,278
+35% +$26.5M 0.05% 210
2022
Q3
$63M Buy
1,625,743
+227,034
+16% +$8.79M 0.07% 253
2022
Q2
$52.1M Sell
1,398,709
-645,611
-32% -$24.1M 0.03% 300
2022
Q1
$90.5M Sell
2,044,320
-607,129
-23% -$26.9M 0.07% 258
2021
Q4
$113M Sell
2,651,449
-169,696
-6% -$7.21M 0.04% 244
2021
Q3
$122M Buy
2,821,145
+703,594
+33% +$30.5M 0.06% 210
2021
Q2
$90.5M Buy
2,117,551
+523,967
+33% +$22.4M 0.04% 249
2021
Q1
$61.6M Buy
1,593,584
+12,069
+0.8% +$466K 0.03% 292
2020
Q4
$56.9M Sell
1,581,515
-53,384
-3% -$1.92M 0.03% 284
2020
Q3
$62.5M Buy
1,634,899
+634,665
+63% +$24.3M 0.04% 235
2020
Q2
$35.1M Sell
1,000,234
-1,940,660
-66% -$68.1M 0.03% 302
2020
Q1
$96M Buy
2,940,894
+733,795
+33% +$23.9M 0.08% 114
2019
Q4
$99.8M Buy
2,207,099
+275,882
+14% +$12.5M 0.06% 194
2019
Q3
$78.6M Sell
1,931,217
-90,243
-4% -$3.67M 0.05% 212
2019
Q2
$86.9M Buy
2,021,460
+489,526
+32% +$21M 0.05% 217
2019
Q1
$58.8M Buy
1,531,934
+173,943
+13% +$6.68M 0.04% 263
2018
Q4
$48M Sell
1,357,991
-248,633
-15% -$8.79M 0.04% 264
2018
Q3
$61.9M Sell
1,606,624
-435,464
-21% -$16.8M 0.04% 230
2018
Q2
$66.8M Sell
2,042,088
-121,996
-6% -$3.99M 0.06% 192
2018
Q1
$59.1M Sell
2,164,084
-139,527
-6% -$3.81M 0.05% 261
2017
Q4
$57.1M Buy
2,303,611
+1,429,713
+164% +$35.4M 0.05% 233
2017
Q3
$25.5M Buy
873,898
+42,724
+5% +$1.25M 0.03% 321
2017
Q2
$23M Buy
831,174
+185,347
+29% +$5.14M 0.02% 316
2017
Q1
$16.1M Buy
645,827
+286,715
+80% +$7.13M 0.02% 377
2016
Q4
$7.77M Buy
359,112
+132,745
+59% +$2.87M 0.01% 593
2016
Q3
$5.39M Sell
226,367
-86,871
-28% -$2.07M 0.01% 640
2016
Q2
$7.32M Sell
313,238
-199,907
-39% -$4.67M 0.01% 581
2016
Q1
$9.24M Buy
513,145
+94,067
+22% +$1.69M 0.01% 463
2015
Q4
$7.54M Buy
419,078
+164,443
+65% +$2.96M 0.01% 537
2015
Q3
$4.07M Sell
254,635
-292,523
-53% -$4.68M ﹤0.01% 773
2015
Q2
$9.3M Sell
547,158
-478,066
-47% -$8.13M 0.01% 590
2015
Q1
$17.4M Sell
1,025,224
-144,431
-12% -$2.46M 0.02% 466
2014
Q4
$15.2M Sell
1,169,655
-394,715
-25% -$5.13M 0.01% 498
2014
Q3
$17.2M Sell
1,564,370
-66,945
-4% -$736K 0.02% 447
2014
Q2
$19.6M Sell
1,631,315
-335,768
-17% -$4.03M 0.02% 399
2014
Q1
$25.6M Sell
1,967,083
-294,138
-13% -$3.82M 0.03% 338
2013
Q4
$27.1M Buy
2,261,221
+436,942
+24% +$5.24M 0.03% 348
2013
Q3
$20.1M Buy
1,824,279
+275,048
+18% +$3.03M 0.02% 357
2013
Q2
$14.4M Buy
+1,549,231
New +$14.4M 0.02% 429